• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    2/6/23 4:06:02 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SC 13G/A 1 schedule13ga2023.htm SC 13G/A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. 29)*
    Hawkins, Inc.
    (Name of Issuer)
    Common Stock, Par Value $.01 per share
    (Title of Class of Securities)

    420261109
    (CUSIP Number)
    December 31, 2022
    (Date of Event Which Requires Filing of this Statement)




    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
        ý Rule 13d-1(b)
        o Rule 13d-1(c)
        o Rule 13d-1(d)
    *    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).





    CUSIP No. 420261109
    13GPage 2 of 5 Pages
    1NAMES OF REPORTING PERSONS
    I.R.S. Identification Nos. of above persons (entities only).

    Hawkins, Inc. Employee Stock Ownership Plan and Trust (Tax ID: 41-0771293)
    Hawkins, Inc. Employee Stock Ownership Plan for Certain Collectively Bargained Employees and Trust (Tax ID: 41-0771293)
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o

                                                                                                                                                                                                (b) o
    3SEC USE ONLY
    4CITIZENSHIP OR PLACE OF ORGANIZATION

    Minnesota
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH:
    5SOLE VOTING POWER

    0
    6SHARED VOTING POWER

    1,077,265.73
    7SOLE DISPOSITIVE POWER

    0
    8SHARED DISPOSITIVE POWER
    1,077,265.73
    9AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,077,265.73
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o
    11PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.1%
    12TYPE OF REPORTING PERSON

    EP





    Item 1.    (a)    Name of Issuer:
    Hawkins, Inc.

    (b)    Address of Issuer’s Principal Executive Offices:
    2381 Rosegate
    Roseville, MN 55113

    Item 2.    (a)    Name of Person Filing: 1
    Hawkins, Inc. Employee Stock Ownership Plan and Trust
    Hawkins, Inc. Employee Stock Ownership Plan for Certain Collectively Bargained Employees and Trust

    (b)    Address of Principal Business Office or, if none, Residence:
    c/o Hawkins, Inc.
    2381 Rosegate
    Roseville, MN 55113

    (c)    Citizenship:
    Minnesota

    (d)    Title of Class of Securities:
    Common Stock, Par Value $.01 per share

    (e)    CUSIP Number:
    420261109

    Item 3.    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)    o    Broker or dealer registered under section 15 of the Act;
    (b)    o    Bank as defined in section 3(a)(6) of the Act;
    (c)    o    Insurance company as defined in section 3(a)(19) of the Act;
    (d)    o    Investment company registered under section 8 of the Investment Company Act of 1940;
    (e)    o    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)    ý    An employee benefit plan or endowment fund in accordance with § 240.13d‑1(b)(1)(ii)(F);
    (g)    o    A parent holding company or control person in accordance with § 240.13d‑1(b)(1)(ii)(G);
    (h)    o    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
    (i)    o    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the
    Investment Company Act;

    (j)    o    A non-U.S. institution in accordance with § 240.13d‑1(b)(1)(ii)(J);

    1 The Trustee of the Hawkins, Inc. Employee Stock Ownership Plan and Trust and the Hawkins, Inc. Employee Stock Ownership Plan for Certain Collectively Bargained Employees and Trust (together, the “ESOP”) is Matrix Trust Company. The ESOP allows plan participants to direct voting of shares allocated to their plan accounts, and all shares held by the ESOP and reported on this Schedule are allocated to plan participant accounts. Under the applicable trust agreement, the Trustee is to vote shares with respect to which no voting instructions are received from plan participants in proportion to the shares voted by plan participants who do submit voting instructions. As a result, the Trustee may theoretically be deemed to share, at least temporarily, voting power as to all shares reported on this Schedule. The Trustee also has limited dispositive power with respect to all shares reported on this Schedule, reflecting a requirement that the assets of the ESOP must primarily consist of shares of the Issuer’s stock. The Trustee disclaims beneficial ownership of the shares attributed to it in its capacity as Trustee of the ESOP.

    3


    (k)    o    Group, in accordance with § 240.13d‑1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
    Item 4.    Ownership
    (a)    Amount beneficially owned: 1,077,265.73.
    (b)    Percent of class: 5.1%.
    (c)    Number of shares as to which such person has:
    (i)    Sole power to vote or to direct the vote 0.
    (ii)    Shared power to vote or to direct the vote 1,077,265.73.
    (iii)    Sole power to dispose or to direct the disposition of 0.
    (iv)    Shared power to dispose or to direct the disposition of 1,077,265.73.
    Item 5.    Ownership of Five Percent or Less of a Class
    Not Applicable
    Item 6.    Ownership of More than Five Percent on Behalf of Another Person.
    The plan participants and beneficiaries of the ESOP have the right to receive dividends from and the proceeds from the sale of the shares reported on this Schedule. No person has such a right with respect to more than 5% of the Issuer’s outstanding common stock.
    Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
    Not Applicable
    Item 8.    Identification and Classification of Members of the Group
    Not Applicable
    Item 9.    Notice of Dissolution of Group
    Not Applicable

    4


    Item 10.    Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 6, 2023    HAWKINS, INC. EMPLOYEE STOCK OWNERSHIP TRUST

    By:    HAWKINS, INC., AS ADMINISTRATOR

    By     /s/ Richard G. Erstad
    Richard G. Erstad
    Vice President, General Counsel and Secretary


    Get the next $HWKN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    7/24/2025Mkt Perform
    Raymond James
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    SEC Filings

    View All

    Hawkins Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HAWKINS INC (0000046250) (Filer)

    8/8/25 7:47:05 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - HAWKINS INC (0000046250) (Filer)

    8/1/25 8:17:38 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 10-Q filed by Hawkins Inc.

    10-Q - HAWKINS INC (0000046250) (Filer)

    7/30/25 4:16:10 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hawkins, Inc. to Participate in the Seaport Research Partners' 14th Annual Summer Investor Conference

    ROSEVILLE, Minn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that Patrick Hawkins, Chief Executive Officer, and Jeff Oldenkamp, Chief Financial Officer, will participate in Seaport Research Partners' 14th Annual Summer Investor Conference. The conference will be held virtually August 19 to August 20, 2025 and is hosted by Seaport Research Partners. It is expected to include over 500 institutional buy-side investors and feature one-on-one and small group meetings. Hawkins will participate on August 20, 2025. For more information about the conference or to schedule a meeting with Hawkins manage

    8/6/25 9:36:14 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A

    7/30/25 4:10:59 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i

    7/30/25 4:05:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Hawkins

    Raymond James initiated coverage of Hawkins with a rating of Mkt Perform

    7/24/25 7:27:35 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins upgraded by BWS Financial with a new price target

    BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00

    4/14/25 9:28:56 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    CJS Securities initiated coverage on Hawkins with a new price target

    CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00

    4/1/25 9:13:14 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Faulconbridge James A bought $161,899 worth of shares (1,800 units at $89.94), increasing direct ownership by 4% to 47,817 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/14/24 4:09:43 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/12/24 6:02:44 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/10/24 4:27:25 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schumacher Mary J. was granted 628 shares, increasing direct ownership by 2% to 26,177 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:20:37 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Spethmann Jeffrey E was granted 628 shares, increasing direct ownership by 12% to 5,911 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:20:15 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Tang Yi was granted 628 shares, increasing direct ownership by 9% to 7,891 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:19:48 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Leadership Updates

    Live Leadership Updates

    View All

    THE TRŪ® SHRIMP COMPANIES APPOINTS HAWKINS AS EXCLUSIVE U.S. DISTRIBUTOR FOR TRŪ® CHITOSAN

    BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph

    8/16/23 9:00:00 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc.  Announces Retirement of Director John McKeon

    Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020.  Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope.  With his support and guidance, we have built a solid company that is poised for cont

    12/18/20 4:10:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hawkins Inc.

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    10/31/24 11:54:59 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    2/13/24 5:06:13 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    2/9/24 9:59:13 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Financials

    Live finance-specific insights

    View All

    Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A

    7/30/25 4:10:59 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i

    7/30/25 4:05:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

    ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

    7/16/25 8:45:00 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary